DOCSLIB.ORG

Annual Review 2001 with the Aim of Improving Human and Animal Health

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Review 2001 with the Aim of Improving Human and Animal Health The Wellcome Trust Annual Review 1 October 2000 – 30 September 2001 Review Annual Trust Wellcome The The Wellcome Trust is an independent research-funding charity, established under the will of Sir Henry Wellcome in 1936. It is funded from a private endowment, which is managed with long-term stability and growth in mind. Its mission is to foster and promote research Annual Review 2001 with the aim of improving human and animal health. Its work covers four areas: Knowledge – improving our understanding of human and animal biology in health and disease, and of the past and present role of medicine in society. Resources – providing exceptional researchers with the infrastructural and career support they need to fulfil their potential. Translation – ensuring maximum health benefits are gained from biomedical research. Public engagement – raising awareness of the medical, ethical and social implications of biomedical science. Contents 1 One of the great strengths of Take, for example, the five new the Wellcome Trust is its diversity. Wellcome Trust Clinical Research In any one day at the Trust, we can Facilities, the first of which opened From the Director discuss issues as diverse as genome in Edinburgh in June 2001.These sequencing, clinical medicine, new centres of patient-oriented 2 Highlights of the year interactive science centres and an research have come about through 18th-century Ottoman manuscript a close working relationship 4 Planning for the future being acquired by the Wellcome between the Trust, the Department 6 Financial summary Library.This breadth of interest of Health, the NHS and universities. gives us the chance to invest not In other areas,Trust research can 8 Knowledge only in stages in the scientific best be taken forward by other Advancing knowledge and process – from ‘blue skies’ research funders.Take, for example, a new understanding in the biomedical through to the development of initiative to control malaria in sciences and their impact on new therapeutics that can be taken Thailand.The Trust’s South-East society – past, present and future. forward to the market – but also Asia unit has developed a new in activities that explore the social combination of drugs that can 18 Resources and cultural implications of control malaria, and this new Contributing to a long-term and scientific research. treatment is now being expanded vibrant research environment. to a large region with a I use the word invest rather than US$4.7 million grant from the Bill 28 Translation funding, because I feel it reflects our and Melinda Gates Foundation. Advancing the translation of Trust- activities more accurately.Through funded research into health benefits. investment in infrastructure, we are A wider perspective putting in place the laboratories In his Nobel address in 1953, 36 Public engagement and equipment our scientists Dr Fritz Lipmann described scientists Engaging with the public through need.Through our personal support thus:“Their purpose often may informed dialogue. schemes, we are investing in be none but just to push back For science should not be confined researchers at all stages of their the limits of our comprehension. to ivory towers; it should be an 46 A year at the Trust careers. And by investing in research Their findings mostly have to be essential part of the culture of the itself, we are laying the foundations expressed in a scientific language country, with everybody able to of knowledge that will underpin that is understood only by a few. take an interest in new scientific UK Funding discoveries of the future. We feel nonetheless that the drive and medical advances. Is such a Career Schemes and Clinical Initiatives and urge to explore nature in all its dream achievable? I would argue International Programmes Continued investment is essential facets is one of the most important that it has to be, and we have to Centres and Initiatives to make use of discoveries and, functions of humanity.” strive to make it so. It is essential Research Partnerships and Ventures in this day and age, such investment that people feel able to voice an Medicine, Society and History on a large scale is essential to drive Fifty years on from Fritz Lipmann’s opinion, debate the implications of Catalyst BioMedica Ltd research forward. In 2000/01, the speech, scientists bring us ever more new advances, and feel proud of Trust awarded grants worth nearly fascinating insights into the workings the achievements of scientists who 60 Board of Governors £400 million, backed a new five- of nature. But more effort must push back the limits of our year research programme at the be made to make such discoveries comprehension. 61 Advisory committees Wellcome Trust Sanger Institute accessible and understandable. with £300 million, and launched a While major breakthroughs such Dr Mike Dexter new £65 million programme in the as the human genome sequence Director of the Wellcome Trust Health Consequences of Population received widespread media coverage May 2002 Change, to name just a few examples and explanation, many other that you will find described in this aspects of science remain couched year’s Annual Review. in a jargonistic language peculiar to the scientific process. By opening That such investment will bring up science to a wider audience – improvements in healthcare I have and publications such as our own no doubt. But to bring about such Wellcome News and the interactive improvements the Trust must work exhibitions at science centres in close partnership with other across the country are just two of funding agencies and institutions. Cover image ‘99 Genetic the ways in which the Trust works Maps of Love’ by Liu Shih-Fen, to do so – science can become an artwork created for the exhibition ‘Working Drafts’, part of society’s consciousness. held in the TwoTen Gallery. Contents 1 One of the great strengths of Take, for example, the five new the Wellcome Trust is its diversity. Wellcome Trust Clinical Research In any one day at the Trust, we can Facilities, the first of which opened From the Director discuss issues as diverse as genome in Edinburgh in June 2001.These sequencing, clinical medicine, new centres of patient-oriented 2 Highlights of the year interactive science centres and an research have come about through 18th-century Ottoman manuscript a close working relationship 4 Planning for the future being acquired by the Wellcome between the Trust, the Department 6 Financial summary Library.This breadth of interest of Health, the NHS and universities. gives us the chance to invest not In other areas,Trust research can 8 Knowledge only in stages in the scientific best be taken forward by other Advancing knowledge and process – from ‘blue skies’ research funders.Take, for example, a new understanding in the biomedical through to the development of initiative to control malaria in sciences and their impact on new therapeutics that can be taken Thailand.The Trust’s South-East society – past, present and future. forward to the market – but also Asia unit has developed a new in activities that explore the social combination of drugs that can 18 Resources and cultural implications of control malaria, and this new Contributing to a long-term and scientific research. treatment is now being expanded vibrant research environment. to a large region with a I use the word invest rather than US$4.7 million grant from the Bill 28 Translation funding, because I feel it reflects our and Melinda Gates Foundation. Advancing the translation of Trust- activities more accurately.Through funded research into health benefits. investment in infrastructure, we are A wider perspective putting in place the laboratories In his Nobel address in 1953, 36 Public engagement and equipment our scientists Dr Fritz Lipmann described scientists Engaging with the public through need.Through our personal support thus:“Their purpose often may informed dialogue. schemes, we are investing in be none but just to push back For science should not be confined researchers at all stages of their the limits of our comprehension. to ivory towers; it should be an 46 A year at the Trust careers. And by investing in research Their findings mostly have to be essential part of the culture of the itself, we are laying the foundations expressed in a scientific language country, with everybody able to of knowledge that will underpin that is understood only by a few. take an interest in new scientific UK Funding discoveries of the future. We feel nonetheless that the drive and medical advances. Is such a Career Schemes and Clinical Initiatives and urge to explore nature in all its dream achievable? I would argue International Programmes Continued investment is essential facets is one of the most important that it has to be, and we have to Centres and Initiatives to make use of discoveries and, functions of humanity.” strive to make it so. It is essential Research Partnerships and Ventures in this day and age, such investment that people feel able to voice an Medicine, Society and History on a large scale is essential to drive Fifty years on from Fritz Lipmann’s opinion, debate the implications of Catalyst BioMedica Ltd research forward. In 2000/01, the speech, scientists bring us ever more new advances, and feel proud of Trust awarded grants worth nearly fascinating insights into the workings the achievements of scientists who 60 Board of Governors £400 million, backed a new five- of nature. But more effort must push back the limits of our year research programme at the be made to make such discoveries comprehension. 61 Advisory committees Wellcome Trust Sanger Institute accessible and understandable. with £300 million, and launched a While major breakthroughs such Dr Mike Dexter new £65 million programme in the as the human genome sequence Director of the Wellcome Trust Health Consequences of Population received widespread media coverage May 2002 Change, to name just a few examples and explanation, many other that you will find described in this aspects of science remain couched year’s Annual Review.
Load more

Recommended publications
  • ANNUAL REVIEW 1 October 2005–30 September
    WELLCOME TRUST ANNUAL REVIEW 1 October 2005–30 September 2006 ANNUAL REVIEW 2006 The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. www.wellcome.ac.uk THE WELLCOME TRUST The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. 123 CONTENTS BOARD OF GOVERNORS 2 Director’s statement William Castell 4 Advancing knowledge Chairman 16 Using knowledge Martin Bobrow Deputy Chairman 24 Engaging society Adrian Bird 30 Developing people Leszek Borysiewicz 36 Facilitating research Patricia Hodgson 40 Developing our organisation Richard Hynes 41 Wellcome Trust 2005/06 Ronald Plasterk 42 Financial summary 2005/06 Alastair Ross Goobey 44 Funding developments 2005/06 Peter Smith 46 Streams funding 2005/06 Jean Thomas 48 Technology Transfer Edward Walker-Arnott 49 Wellcome Trust Genome Campus As at January 2007 50 Public Engagement 51 Library and information resources 52 Advisory committees Images 1 Surface of the gut. 3 Zebrafish. 5 Cells in a developing This Annual Review covers the 2 Young children in 4 A scene from Y fruit fly. Wellcome Trust’s financial year, from Kenya. Touring’s Every Breath. 6 Data management at the Sanger Institute. 1 October 2005 to 30 September 2006. CONTENTS 1 45 6 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health.
    [Show full text]
  • The Fourth Report of Senior Pay and Perks in UK Universities History This
    Transparency at the top? The fourth report of senior pay and perks in UK universities History This is the fourth report on pay and perks at the top of British higher education institutions (HEIs) to be published by the University and College Union (UCU). It forms part of the union’s ongoing campaign for greater transparency in higher education, including the rationale behind senior pay rises. UCU submitted a Freedom of Information (FoI) request to 158 HEIs in October 2017. This followed similar requests submitted in 2016, 2015 and 2014. All requests were designed to shine a light on the arbitrary nature of senior pay and perks in universities, and support the union’s call for reform. The basis for this report The FoI request that forms the basis of this report was sent to 158 (HEIs). It requested details of vice-chancellors’ (or head of institution if known by a different title) salaries and those of other senior post-holders earning over £100,000 at the institution during the academic year of 2016/17 (1 August 2016 to 31 July 2017). It also asked for details of flights, spending on hotels, spending on expenses and if the vice-chancellor was provided with accommodation by the university. Finally, we requested to know whether or not the vice-chancellor was a member of the remuneration committee, and requested a copy of the most recently ratified minutes of the institution’s remuneration committee. Variety of responses The questions on expenditure on flights, hotels, expenses and accommodation for vice-chancellors elicited a huge variation in responses with many institutions deploying exemptions under the Freedom of Information Act to avoid providing data.
    [Show full text]
  • CTRI Trial Data
    PDF of Trial CTRI Website URL - http://ctri.nic.in Clinical Trial Details (PDF Generation Date :- Tue, 28 Sep 2021 15:39:14 GMT) CTRI Number CTRI/2009/091/001080 [Registered on: 28/06/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of Study Study Design Randomized, Parallel Group, Placebo Controlled Trial Public Title of Study A clinical Trial to study the safety, immunogenicity and tolerability of a tetravalent rotavirus vaccine in Indian infants. Scientific Title of Phase I/II, randomized, double-blind, placebo-controlled, dosage selection (10e5.5 or 10e6.25 FFU Study of each constituent serotype per 0.5 mL) study to evaluate the safety, tolerability, and immunogenicity of a 3-dose series of Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] administered to healthy Indian infants. Secondary IDs if Any Secondary ID Identifier NCT01061658 ClinicalTrials.gov SBL/BRV-TV/Form1/PhI/2009/0100 Protocol Number SBL/BRV-TV/Form1/PhI/2009/0100 Protocol Number Details of Principal Details of Principal Investigator Investigator or overall Name Dr. Gagandeep Kang Trial Coordinator (multi-center study) Designation Affiliation Address Department of Gastrointestinal Sciences, Christian Medical College Vellore TAMIL NADU 632004 India Phone 0416-2282052 Fax 0416-2282486 Email [email protected] Details Contact Details Contact Person (Scientific Query) Person (Scientific Name Dr. Raman Rao Query) Designation Affiliation Shantha Biotechnics Limited Address VP, R&D, 4th Floor, Vasantha Chambers, Fateh Maidan Road, Basheer Bagh Hyderabad ANDHRA PRADESH 500004 India Phone 040-66301800 Fax 040-23234133 Email [email protected] Details Contact Details Contact Person (Public Query) Person (Public Query) Name Dr.
    [Show full text]
  • “Women Rarely Put Themselves Forward Despite Being Very Capable.”
    IN CONVERSATION “Women rarely put themselves forward despite being very capable.” Professor Gagandeep Kang is currently the Executive Director of Translational Health Science and Technology Institute (THSTI), Faridabad. She is the first Indian woman scientist to be elected as Fellow of Royal Society (FRS) by the Royal Society in the UK. She is a leading scientist with over 300 scientific research papers published on diarrhoeal infections in children, mainly from work done at the Christian Medical College (CMC) in Vellore. Amongst several awards, she is the recipient of the Infosys Life Sciences Award in 2016. She is a member of many review and advisory committees for national and international funding agencies related to public health. Dr. Kang has chaired the WHO SEAR’s Regional Immunization Technical Advisory Group since 2015. In an interview given to PARUL R. SHETH for Science Reporter, Dr Gagandeep Kang talks about her work on rotaviruses, safety of Indian vaccines, the advantages and disadvantages of being a woman in science, and her experiences with community health programmes. 20 | Science Reporter | June 2019 GAGANDEEP KANG: My colleague, Ira and I published a PARUL R. SHETH: Congratulations to you for being the paper a couple of years ago, comparing children of doctors and first woman scientist to be elected as FRS in 360 years! This children who lived in urban slum areas, showing that middle indeed is a great honour and we are all proud of you. Your class Indian children carry in their guts one-fourth the number work has been recognised for its quality and impact.
    [Show full text]
  • History of Badminton
    Facts and Records History of Badminton In 1873, the Duke of Beaufort held a lawn party at his country house in the village of Badminton, Gloucestershire. A game of Poona was played on that day and became popular among British society’s elite. The new party sport became known as “the Badminton game”. In 1877, the Bath Badminton Club was formed and developed the first official set of rules. The Badminton Association was formed at a meeting in Southsea on 13th September 1893. It was the first National Association in the world and framed the rules for the Association and for the game. The popularity of the sport increased rapidly with 300 clubs being introduced by the 1920’s. Rising to 9,000 shortly after World War Π. The International Badminton Federation (IBF) was formed in 1934 with nine founding members: England, Ireland, Scotland, Wales, Denmark, Holland, Canada, New Zealand and France and as a consequence the Badminton Association became the Badminton Association of England. From nine founding members, the IBF, now called the Badminton World Federation (BWF), has over 160 member countries. The future of Badminton looks bright. Badminton was officially granted Olympic status in the 1992 Barcelona Games. Indonesia was the dominant force in that first Olympic tournament, winning two golds, a silver and a bronze; the country’s first Olympic medals in its history. More than 1.1 billion people watched the 1992 Olympic Badminton competition on television. Eight years later, and more than a century after introducing Badminton to the world, Britain claimed their first medal in the Olympics when Simon Archer and Jo Goode achieved Mixed Doubles Bronze in Sydney.
    [Show full text]
  • Annual Meeting
    Volume 97 | Number 5 Volume VOLUME 97 NOVEMBER 2017 NUMBER 5 SUPPLEMENT SIXTY-SIXTH ANNUAL MEETING November 5–9, 2017 The Baltimore Convention Center | Baltimore, Maryland USA The American Journal of Tropical Medicine and Hygiene The American Journal of Tropical astmh.org ajtmh.org #TropMed17 Supplement to The American Journal of Tropical Medicine and Hygiene ASTMH FP Cover 17.indd 1-3 10/11/17 1:48 PM Welcome to TropMed17, our yearly assembly for stimulating research, clinical advances, special lectures, guests and bonus events. Our keynote speaker this year is Dr. Paul Farmer, Co-founder and Chief Strategist of Partners In Health (PIH). In addition, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, will deliver a plenary session Thursday, November 9. Other highlighted speakers include Dr. Scott O’Neill, who will deliver the Fred L. Soper Lecture; Dr. Claudio F. Lanata, the Vincenzo Marcolongo Memorial Lecture; and Dr. Jane Cardosa, the Commemorative Fund Lecture. We are pleased to announce that this year’s offerings extend beyond communicating top-rated science to direct service to the global community and a number of novel events: • Get a Shot. Give a Shot.® Through Walgreens’ Get a Shot. Give a Shot.® campaign, you can not only receive your free flu shot, but also provide a lifesaving vaccine to a child in need via the UN Foundation’s Shot@Life campaign. • Under the Net. Walk in the shoes of a young girl living in a refugee camp through the virtual reality experience presented by UN Foundation’s Nothing But Nets campaign.
    [Show full text]
  • CRISPR and Beyond Perturbations at Scale to Understand Genomes 2-4
    CRISPR and Beyond Perturbations at Scale to Understand Genomes 2-4 September 2019 Wellcome Genome Campus, UK Lectures to be held in the Francis Crick Auditorium Lunch and dinner to be held in the Hall Restaurant Poster sessions to be held in the Conference Centre Spoken presentations - If you are an invited speaker, or your abstract has been selected for a spoken presentation, please give an electronic version of your talk to the AV technician. Poster presentations – If your abstract has been selected for a poster, please display this in the Conference Centre on arrival. Conference programme Monday, 2 September 2019 11:45-12:50 Registration 12:50-13:00 Welcome and introductions Leopold Parts, Wellcome Sanger Institute UK 13.00-14.00 Keynote lecture Allan Bradley Kymab, UK 14:00-15:30 Session 1: Understanding impact of coding variations Chair: Leopold Parts, Wellcome Sanger Institute UK 14:00 New approaches for addressing the effect of genetic variation at scale Douglas Fowler University of Washington, USA 14:30 Tools for systematic proactive functional testing of human missense variants Frederick Roth University of Toronto 15:00 The mutational landscape of a prion-like domain Benedetta Bolognesi Institute for Bioengineering of Catalonia, Spain 15:15 Functional determination of all possible disease-associated variants in a region of CARD11 using saturation genome editing Richard James University of Washington, USA 15:30-16:00 Afternoon tea 16:00-17:30 Session 2: Measuring consequences of non-coding variation Chair: Lea Starita, University
    [Show full text]
  • A Catalogue of the Fellows, Candidates, Licentiates [And Extra
    MDCCCXXXVI. / Od- CATALOGUE OF THE FELLOWS, CANDIDATES, AND LICENTIATES, OF THE ftogal College of LONDON. STREET. PRINTED 1!Y G. WGOUFAM., ANGEL COURT, SKINNER A CATALOGUE OF THE FELLOWS, CANDIDATES, AND LICENTIATES, OF THE Ittojjal College of ^ijpstrtans, LONDON. FELLOWS. Sir Henry Halford, Bart., M.D., G.C.IL, President, Physician to their Majesties , Curzon-street . Devereux Mytton, M.D., Garth . John Latham, M.D., Bradwall-hall, Cheshire. Edward Roberts, M.D. George Paulet Morris, M.D., Prince s-court, St. James s-park. William Heberden, M.D., Elect, Pall Mall. Algernon Frampton, M.D., Elect, New Broad- street. Devey Fearon, M.D. Samuel Holland, M.D. James Franck, M.D., Bertford-street. Park- lane. Sir George Smith Gibbes, Knt., M.D. William Lambe, M.D., Elect, Kings-road, Bedford-row. John Johnstone, M.D., Birmingham. Sir James Fellowes, Knt., M.D., Brighton. Charles Price, M.D., Brighton. a 2 . 4 Thomas Turner, M.D., Elect, and Trea- Extraordinary to surer, Physician the Queen , Curzon-street Edward Nathaniel Bancroft, M.D., Jamaica. Charles Dalston Nevinson, M.D., Montagu- square. Robert Bree, M.D., Elect, Park-square , Regent’s-park. John Cooke, M.D., Gower-street Sir Arthur Brooke Faulkner, Knt., M.D., Cheltenham. Thomas Hume, M.D., Elect, South-street , Grosvenor-square. Peter Rainier, M.D., Albany. Tristram Whitter, M.D. Clement Hue, M.D., Elect, Guildford- street. John Bright, M.D., Manchester-square. James Cholmeley, M.D., Bridge-street Henry , Blackfriars. Sir Thomas Charles Morgan, Knt., M.D., Dublin. Richard Simmons, M.D. Joseph Ager, M.D., Great Portland-st.
    [Show full text]
  • Strategic Plan 2011-2016
    Strategic Plan 2011-2016 Wellcome Trust Sanger Institute Strategic Plan 2011-2016 Mission The Wellcome Trust Sanger Institute uses genome sequences to advance understanding of the biology of humans and pathogens in order to improve human health. -i- Wellcome Trust Sanger Institute Strategic Plan 2011-2016 - ii - Wellcome Trust Sanger Institute Strategic Plan 2011-2016 CONTENTS Foreword ....................................................................................................................................1 Overview .....................................................................................................................................2 1. History and philosophy ............................................................................................................ 5 2. Organisation of the science ..................................................................................................... 5 3. Developments in the scientific portfolio ................................................................................... 7 4. Summary of the Scientific Programmes 2011 – 2016 .............................................................. 8 4.1 Cancer Genetics and Genomics ................................................................................ 8 4.2 Human Genetics ...................................................................................................... 10 4.3 Pathogen Variation .................................................................................................. 13 4.4 Malaria
    [Show full text]
  • Fiona Fox Chief ExecuVe
    Fiona Fox Chief Execu+ve Set up in 2002 aer things went very wrong: - MMR & au;sm - GM crops - BSE - Animal research AIMS Vision Policy decisions and public debate informed by accurate, evidence-based scien7fic informaon in the news media Mission To make it easier for journalists to access the best science when stories hit the headlines and to ensure that more scien7sts engage with the media when stories hit the headlines Values Reliable, fast, accurate, authoritave, independent, media savvy SMC Philosophy " We’ll get the media to ‘DO’ science better when scientists ‘DO’ media better " Animal research in the UK media 1. The Bad Old Days Reac;ng to animal extremism 1980s – 1990s - Almost every story is on extremism - Only a handful of scien;sts prepared to speak out - Animal research covered by general and polical reporters - Funders and government stay quiet Legislave, judicial & Animal ac;vist / extremist ac;vity Science & medical governmental acon community acon 1997 (July) Consort Kennels in Hereford, a laboratory beagle breeder, closes aer a 10-month animal rights campaign including the theG of 26 beagles. 1999 (August) Hillgrove Farm in Oxfordshire, the UK's only commercial breeder of laboratory cats, closes aer a violent three year campaign. (Jan) Cambridge University abandons plan 2004 for new primate laboratory aer intense campaigning. (Oct) Darley Oaks Farm in Staffordshire closes its guinea pig breeding business aer a violent six-year campaign including digging up the grave of Gladys Hammond, the owners’ mother-in-law, sparking
    [Show full text]
  • November 2013
    LONDONLONDON MATHEMATICALMATHEMATICAL SOCIETYSOCIETY NEWSLETTER No. 430 November 2013 Society MeetingsSociety ONE THOUSAND to publicise LMS activities and Meetings AND COUNTING mathematics more generally, and Events and leave with a range of pub- and Events Three hundred people visited De lications including the Annual 2013 Morgan House on Sunday 22 Sep- Review and information about tember 2013 as part of the an- membership, grants and Women Friday 15 November nual London Open House event. in Mathematics. LMS Graduate Student Since first participating in Open The feedback from visitors Meeting, London House three years ago over 1,000 was again very positive. The LMS page 4 people have visited De Morgan will continue to develop its pres- Friday 15 November House, learning about the Society ence at the event and is already LMS AGM, London and mathematics more generally. discussing a more comprehen- page 5 sive programme for next year. 1 Monday 16 December SW & South Wales 2013 ELECTIONS Regional Meeting, TO COUNCIL AND Swansea page 13 NOMINATING 18-20 December COMMITTEE LMS Prospects in Members should now have re- Mathematics, Durham ceived a communication from the page 14 Electoral Reform Society (ERS) for both e-voting and paper ballot. 2014 For online voting, members may cast a vote by going to www.vote- Friday 28 February byinternet.com/LMS2013 and us- Mary Cartwright ing the two part security code on Lecture, York the email sent by the ERS and also Monday 31 March on their ballot paper. Northern Regional All members are asked to look Meeting, Durham out for communication from page 19 At this year’s event visitors the ERS.
    [Show full text]
  • Medico-Chirurgical Transactions
    MEDICO-CHIRURGICAL TRANSACTIONS. PUBLISHED BY THE ROYAL MEDICAL AND CHIIRURGICAL SOCIETY OF LONDON. VOLUME THE SIXTY-THIRD. LONDON: LONGMANS, GREEN, READER, AND DYER, PATERNOSTER ROW. 1880. i........OO.EOHTR:IJRQIOA .'.TRANSACTIONS.- THE ROYAL MEDICAL AND. CIUURGICAL SOCIETY * ~~~or LONDON. SECOND SERIES. VOLUME THE FORTY-PffmT LONDON: LONGMANS, G[REN, READER, AND DYER, PATERNOSTER ROW. 1880. PRINTED BY J. E. ADLARD, BARTHOLOXEW COSE. ROYAL MEDICAL AND CHIRURGICAL SOCIETY OF LONDON. PATRON. THE QUEEN. OFFICERS AND COUNCIL, ELECTED MARCH 1, 1880. 8resihet,t JOHN ERIC ERICHSEN, F.R.S. rCHARLES BLAND RADCLIFFE, M.D. ALFRED BARING GARROD, M.D., F.R.S. VICE-PRESIDENTS. BARNARD WIGHT HOLT. LJOHN BIRKETT. r WILLIAM WEGG, M.D. TREASURERS. l JOHN COOPER FORSTER. { REGINALD EDWARD THOMPSON, M.D. SECRETARIES. TIMOTHY HOLMES. GEORGE JOHNSON, M.D., F.R.S. LIBRARIANS. L l JOHN WHITAKER HULKE, F.R.S. r JOHN LANGDON H. DOWN, M.D. CHARLES HILTON FAGGE, M.D. SAMUEL FENVICK, M.D. JOHN HARLEY, M.D. OTHER MEMBERS J GEORGE ROPER, M.D. OF COUNCIL. ] FREDERICK JAMES GANT. CHRISTOPHER HEATH. FRANCIS MASON. JOHN MORGAN. ALFRED WILLETT. THE ABOVE FORM THE COUNCIL. RESIDENT ASSISTANT-LIBRARIAN. BENJAMIN ROBERT WHEATLEY. A LIST OF THE PRESIDENTS OF THE SOCIETY FROM ITS FORMATION. ELECTED 1805. WILLIAM SAUNDERS, M.D. 1808. MATTHEW BAILLIE, M.D. 1810. SIR HENRY HALFORD, BART., M.D., G.C.H. 1813. SIR GILBERT BLANE, BART., M.D. 1815. HENRY CLINE. 1817. WILLIAM BABINGTON, M.D. 1819. SIR ASTLEY PASTON COOPER, BART., K.C.H., D.C.L. 1821. JOHN COOKE, M.D. 1823. JOHN ABERNETHY. 1825.
    [Show full text]